BTL Aesthetics recently celebrated the significant milestone of reaching 1 MILLION treatments of its iconic Emsculpt® and Emsculpt NEO® brands. Utilising BTL’s patented and ground-breaking HIFEM+® technology in combination with synchronised radiofrequency for the revolutionary treatment of non-invasive body shaping and contouring, making it one of the fastest Aesthetic device brands to reach 1 million treatments globally.
Backed by over 40 clinical publications and independent trials, HIFEM® technology is one of the most in-depth researched technologies. The clinical trials utilise the most established methods of evaluation including MRI, human histology, CT, and ultrasound. All the latest clinical studies of EMSCULPT NEO® involve more than 500 patients and 30 investigators showing on average:
- 25% more muscles
- 30% less fat
- 19% reduction in abdominal separation
- Effects were comparable to a 12–16 week exercise workout program.
FEATURES
- 20,000 supramaximal contractions in 30 minutes, requiring only 4 sessions
- The largest spot size in the industry producing stronger contractions and more activated muscles than other technologies*
- The only technology proven to reduce visceral and superficial fat
- High ROI
‘MY PATIENTS LOVE EMSCULPT NEO®.’
– Brian M. Kinney, MD, Plastic Surgeon, Los Angeles, California
‘I HAVE NOT SEEN ANYTHING LIKE EMSCULPT NEO® BEFORE.’
– Richard Goldfarb, MD, FACS, Cosmetic Surgeon, Pennsylvania
‘WITH THE ADDITIONAL SEVEN NEW CLINICAL STUDIES, EMSCULPT
NEO® HAS DEMONSTRATED SUPERIOR EFFICACY.’
– Frank Lin, MD, Plastic Surgeon, Melbourne
‘MY CLIENTS AND STAFF HAVE HAD SO MUCH SUCCESS WITH IT, THAT I HAVE INVESTED AN ADDITIONAL EMSCULPT NEO® IN LESS THAN 6 MONTHS TO KEEP UP WITH THE DEMAND.’
– Saras Sundrum, MD, Cosmetic Physician, Sydney
For more information contact BTL Aesthetics:
P +61 435 769 639
E info@btlmed.com.au
www.btlaesthetics.com/au
PRODUCT RANGES
BTL EMSELLA®
